Scapular dyskinesis in myotonic dystrophy type 1: clinical characteristics and genetic investigations.


Journal

Journal of neurology
ISSN: 1432-1459
Titre abrégé: J Neurol
Pays: Germany
ID NLM: 0423161

Informations de publication

Date de publication:
Dec 2019
Historique:
received: 25 04 2019
accepted: 30 07 2019
revised: 26 07 2019
pubmed: 1 9 2019
medline: 15 4 2020
entrez: 1 9 2019
Statut: ppublish

Résumé

To study scapular winging or other forms of scapular dyskinesis (condition of alteration of the normal position and motion of the scapula) in myotonic dystrophy type 1 (DM1), which is generally considered to be a distal myopathy, we performed an observational cohort study. We performed a prospective cohort study on the clinical features and progression over time of 33 patients with DM1 and pronounced, mostly asymmetric scapular winging or other forms of scapular dyskinesis. We also explored if scapular dyskinesis in DM1 has the same genetic background as in facioscapulohumeral muscular dystrophy type 1 (FSHD1). The cohort included patients with congenital (n = 3), infantile (n = 6) and adult-onset DM1 (n = 24). Scapular girdle examination showed moderate shoulder girdle weakness (mean MRC 3) and atrophy of trapezius, infraspinatus, and rhomboid major, seemingly similar as in FSHD1. Shoulder abduction and forward flexion were limited (50-70°). In five patients, scapular dyskinesis was the initial disease symptom; in the others it appeared 1-24 years after disease onset. Follow-up data were available in 29 patients (mean 8 years) and showed mild to severe increase of scapular dyskinesis over time. In only three patients, DM1 coexisted with a FSHD mutation. In all other patients, FSHD was genetically excluded. DM2 was genetically excluded in nine patients. The clinical features of the patients with both DM1 and FSHD1 mutations were similar to those with DM1 only. Scapular dyskinesis can be considered to be part of DM1 in a small proportion of patients. In spite of the clinical overlap, FSHD can explain scapular dyskinesis only in a small minority. This study is expected to improve the recognition of shoulder girdle involvement in DM1, which will contribute to the management of these patients.

Identifiants

pubmed: 31471688
doi: 10.1007/s00415-019-09494-8
pii: 10.1007/s00415-019-09494-8
pmc: PMC6851043
doi:

Types de publication

Journal Article Observational Study

Langues

eng

Sous-ensembles de citation

IM

Pagination

2987-2996

Subventions

Organisme : NINDS NIH HHS
ID : P01 NS069539
Pays : United States

Références

Am J Hum Genet. 2010 Mar 12;86(3):364-77
pubmed: 20206332
J Am Acad Orthop Surg. 2003 Mar-Apr;11(2):142-51
pubmed: 12670140
Hum Mol Genet. 2015 Feb 1;24(3):659-69
pubmed: 25256356
Neuromuscul Disord. 2012 Aug;22(8):755-8
pubmed: 22683376
Neuromuscul Disord. 2013 May;23(5):427-31
pubmed: 23466272
Eur J Hum Genet. 2018 Jan;26(1):94-106
pubmed: 29162933
J Neurol. 2002 May;249(5):629-30
pubmed: 12021957
Muscle Nerve. 2017 Jul;56(1):7-14
pubmed: 28006862
Nat Genet. 2012 Dec;44(12):1370-4
pubmed: 23143600
Clin Orthop Relat Res. 1984 May;(185):228-36
pubmed: 6705385
Rev Neurol (Paris). 2016 Oct;172(10):572-580
pubmed: 27665240
J Biomech. 2000 Sep;33(9):1063-8
pubmed: 10854878
Am J Hum Genet. 2012 Apr 6;90(4):628-35
pubmed: 22482803
J Clin Neurosci. 2007 Jan;14(1):27-32
pubmed: 17092719
J Electromyogr Kinesiol. 2018 Feb;38:88-93
pubmed: 29179028
Eur J Paediatr Neurol. 2008 May;12(3):210-23
pubmed: 17892958
Science. 2010 Sep 24;329(5999):1650-3
pubmed: 20724583
Neurology. 2001 Feb 13;56(3):336-40
pubmed: 11171898
Hum Mol Genet. 2018 Oct 15;27(20):3488-3497
pubmed: 30281091
Rinsho Shinkeigaku. 1999 Apr;39(4):461-4
pubmed: 10391974
J Am Acad Orthop Surg. 2011 Aug;19(8):453-62
pubmed: 21807913
J Shoulder Elbow Surg. 2013 Apr;22(4):e11-9
pubmed: 22947240
Muscle Nerve. 2016 Aug;54(2):339-40
pubmed: 26969833

Auteurs

N C Voermans (NC)

Department of Neurology, Donders Institute for Brain, Cognition and Behaviour, Radboud University Medical Center, Nijmegen, The Netherlands. nicol.voermans@radboudumc.nl.

R C van der Bilt (RC)

Department of Neurology, Donders Institute for Brain, Cognition and Behaviour, Radboud University Medical Center, Nijmegen, The Netherlands.

J IJspeert (J)

Department of Rehabilitation, Donders Institute for Brain, Cognition and Behaviour, Radboud University Medical Center, Radboudumc, PO Box 9101, 6500, HB, Nijmegen, The Netherlands.

J Y Hogrel (JY)

AP-HP; Centre de référence des maladies neuromusculaires Nord-Est-Ile de France, Institut de Myology, Paris, France.

M Jeanpierre (M)

AP-HP, Hôpital Cochin, Paris, France.

A Behin (A)

AP-HP; Centre de référence des maladies neuromusculaires Nord-Est-Ile de France, Institut de Myology, Paris, France.

P Laforet (P)

Neurology Department, Raymond Poincaré Teaching Hospital, Nord/Est/Ile de France Neuromuscular Center, AP-HP Garches, Garches, France.
INSERM U1179, END-ICAP, Université Versailles Saint-Quentin-en-Yvelines, Montigny-le-Bretonneux, France.

T Stojkovic (T)

AP-HP; Centre de référence des maladies neuromusculaires Nord-Est-Ile de France, Institut de Myology, Paris, France.

B G van Engelen (BG)

Department of Neurology, Donders Institute for Brain, Cognition and Behaviour, Radboud University Medical Center, Nijmegen, The Netherlands.

G W Padberg (GW)

Department of Neurology, Donders Institute for Brain, Cognition and Behaviour, Radboud University Medical Center, Nijmegen, The Netherlands.

S Sacconi (S)

Université Côte d'Azur, Peripheral Nervous System, Centre Hospitalier Universitaire de Nice, Muscle and ALS department, Nice, France.
Inserm CNRS, Institute for Research on Cancer and Aging of Nice (IRCAN), Université Côte d'Azur, Nice, France.

R J L F Lemmers (RJLF)

Department of Human Genetics, Leiden University Medical Center, Leiden, The Netherlands.

S M van der Maarel (SM)

Department of Human Genetics, Leiden University Medical Center, Leiden, The Netherlands.

B Eymard (B)

AP-HP; Centre de référence des maladies neuromusculaires Nord-Est-Ile de France, Institut de Myology, Paris, France.

G Bassez (G)

AP-HP; Centre de référence des maladies neuromusculaires Nord-Est-Ile de France, Institut de Myology, Paris, France.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH